Replies to post #840 on Fate Therapeutics Inc (FATE)

[jondoeuk]

They will initiate an ITT for FT836 in multiple myeloma. The first patient should be enrolled in 1H 2026.

[jondoeuk]

The PR https://www.globenewswire.com/news-release/2025/12/08/3201474/24675/en/Fate-Therapeutics-Presents-Updated-Phase-1-Clinical-Data-of-FT819-Off-the-shelf-CAR-T-cell-Product-Candidate-for-Systemic-Lupus-Erythematosus-and-Preclinical-Advances-in-Next-Gener.html

Posters https://www.fatetherapeutics.com/wp-content/uploads/2025/12/2350-Soheila-ASH2025-poster.pdf

https://www.fatetherapeutics.com/wp-content/uploads/2025/12/ASH-2025-FT819-FT839_Autoimmunity_FATE_FOR-PRINT-03Dec2025.pdf

https://www.fatetherapeutics.com/wp-content/uploads/2025/12/ASH-2025-Shilpi-Chandra-Abstract-4121.pdf